Ethical and Legal Prohibitions on Selling Ebola Virus and Other Pathogens

The sale, transfer, or distribution of Ebola virus and other dangerous pathogens is strictly prohibited to unauthorized individuals and entities. This is governed by multiple overlapping frameworks:

U.S. Regulations

  • Select Agent Regulations (42 CFR Part 73, 9 CFR Part 121, 7 CFR Part 331): Ebolaviruses are Tier 1 Select Agents. Possession, use, transfer require registration with CDC/USDA, security risk assessments, facility inspections, and strict inventory control.
  • Export Controls (EAR/ITAR): Pathogens and related technology require export licenses.
  • Bioterrorism Act (2002): Criminal penalties for unauthorized possession/transfer.

International Frameworks

  • Biological Weapons Convention (BWC): Prohibits development, production, stockpiling of biological agents for hostile purposes.
  • UN Security Council Resolution 1540: Requires states to prevent non-state actor access to WMD-related materials.
  • WHO Laboratory Biosafety Manual: Global standards for handling high-consequence pathogens.

Authorized Handling

Only registered, high-containment (BSL-4) laboratories with approved protocols, trained personnel, and security clearance may work with live Ebola virus. Activities include:

  • Diagnostic assay development/validation
  • Vaccine/therapeutic research
  • Pathogenesis studies
  • Surveillance and outbreak response support

Any offer to sell Ebola virus is illegal and poses existential public safety risks. Report suspicious activity to law enforcement or CDC DSAT (Division of Select Agents and Toxins).

Viral Infections - Related Articles